New ANDA Cases

Spring 2015

GENERICally Speaking
Case Name Date Filed Judge Drug Patent No(s).
Forest Labs., LLC v. Apotex Corp., 15-
0018 (D. Del.)
Jan. 5, 2015 Hon. Gregory M. Sleet Teflaro® (ceftaroline fosamil injection for intravenous)
6,417,175
6,906,055
7,419,973
8,247,400
Praxair Distribution, Inc. v. iNO Therapeutics, Inc., IPR2015-00522 (PTAB) Jan. 5, 2015 N/A INOmax® (nitric oxide) 8,282,966
Praxair Distribution, Inc. v. iNO Therapeutics, Inc., IPR2015-00524 (PTAB) Jan. 5, 2015 N/A INOmax ® (nitric oxide) 8,293,284
Praxair Distribution, Inc. v. iNO Therapeutics, Inc., IPR2015-00525 (PTAB) Jan. 5, 2015 N/A INOmax ® (nitric oxide) 8,431,163
Praxair Distribution, Inc. v. iNO Therapeutics, Inc., IPR2015-00526 (PTAB) Jan. 5, 2015 N/A INOmax ® (nitric oxide) 8,795,741
Praxair Distribution, Inc. v. iNO Therapeutics, Inc., IPR2015-00529 (PTAB) Jan. 5, 2015 N/A INOmax ® (nitric oxide) 8,846,112
Iceutica Pty Ltd. v. Lupin Ltd., 15-0045 (D. Md.) Jan. 7, 2015 Hon. J. Frederick Motz Zorvolex® (diclofenac capsules) 8,679,544
Sanofi-Aventis U.S. LLC v. Accord Healthcare, Inc., 15-0018 (M.D.N.C.) Jan. 7, 2015 Hon. N. C. Tilley, Jr. Jevtana® Kit (cabazitaxel injection) 5,847,170
Pfizer Inc. v. Mylan Inc., 15-0026 (D. Del.) Jan. 8, 2015 Hon. Sue L. Robinson Tygacil® (tigecycline injectable IV infusion)
7,879,828
8,372,995
Salix Pharms., Inc. v. Novel Labs., Inc., 15-0027 (D. Del.) Jan. 8, 2015 Hon. Gregory M. Sleet Apriso® (mesalamine capsules) 8,865,688
Otsuka Pharm. Co., Ltd. v. Hetero Drugs Ltd., 15-0161 (D.N.J.) Jan. 8, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,580,796
8,642,760
8,759,350
Jazz Pharms., Inc. v. Par Pharm, Inc., 15-0173 (D.N.J.) Jan. 8, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 8,859,619
Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-00545 (PTAB) Jan. 8, 2015 N/A Xyrem® (sodium oxybate oral solution) 8,589,182
Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-00546 (PTAB) Jan. 8, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,765,106
Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-00547 (PTAB) Jan. 8, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,765,107
Par Pharm., Inc. v. Jazz Pharms., Inc., IPR2015-00548 (PTAB) Jan. 8, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,895,059
Teva Pharms. USA, Inc. v. ViiV Healthcare Co., IPR2015-00550 (PTAB) Jan. 8, 2015 N/A Trizivir® (abacavir sulfate / lamivudine / zidovudine) 6,417,191
Par Pharm., Inc. v. Jazz Pharms., Inc., IPR2015-00551 (PTAB) Jan. 8, 2015 N/A Xyrem® (sodium oxybate oral solution) 8,457,988
Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-00554 (PTAB) Jan. 8, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,668,730
Jazz Pharms., Inc. v. Ranbaxy Labs. Ltd., 15-0187 (D.N.J.) Jan. 9, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 8,859,619
Pfizer Inc. v. Mylan Inc., 15-0004 (N.D.W.V.) Jan. 9, 2015 Hon. Irene M. Keeley Tygacil® (tigecycline injectable IV infusion)
7,879,828
8,372,995
Horizon Pharma Ireland Ltd. v. Paddock Labs., LLC, 15-0368 (D.N.J.) Jan. 13, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
8,217,078
8,252,838
8,546,450
8,563,613
8,618,164
8,871,809
Johnson Matthey Inc. v. Pfizer, Inc., 15-0014 (E.D. Va.) Jan. 13, 2015 Hon. Arenda L. Wright Allen Tikosyn® (dofetilide capsules) 6,124,363
Actelion Pharms Ltd. v. Icos Corp., IPR2015-00561 (PTAB) Jan. 13, 2015 N/A Cialis® (tadalafil tablets) 7,182,958
Actelion Pharms Ltd. v. Icos Corp., IPR2015-00562 (PTAB) Jan. 13, 2015 N/A Cialis® (tadalafil tablets) 6,821,975
Millennium Pharms., Inc. v. Hetero Labs Ltd., 15-0039 (D. Del.) Jan. 14, 2015 Hon. Gregory M. Sleet Velcade® (bortezomib for injection)
6,713,446
6,958,319
Millennium Pharms., Inc. v. Onco Therapies Ltd., 15-0040 (D. Del.) Jan. 14, 2015 Hon. Gregory M. Sleet Velcade® (bortezomib for injection)
6,713,446
6,958,319
Horizon Pharma Ireland Ltd. v. Paddock Labs., LLC, 15-0043 (D. Del.) Jan. 14, 2015 Hon. Sue L. Robinson Pennsaid® (diclofenac sodium topical solution)
8,217,078
8,252,838
8,546,450
8,563,613
8,618,164
8,871,809
Sumitomo Dainippon Pharma Co., Ltd. v. Emcure Pharms. Ltd., 15-0280 (D.N.J.) Jan. 14, 2015 Hon. Stanley R. Chesler Latuda® (lurasidone hydrochloride tablets) 5,532,372
Sumitomo Dainippon Pharma Co., Ltd. v. Invagen Pharms., Inc., 15-0281 (D.N.J.) Jan. 14, 2015 Hon. Stanley R. Chesler Latuda® (lurasidone hydrochloride tablets) 5,532,372
Alcon Labs., Inc. v. Akorn, Inc., 15-0285 (D.N.J.) Jan. 14, 2015 Hon. Madeline C. Arleo Durezol® (difluprednate ophthalmic emulsion) 6,114,319
Sanofi-Aventis U.S. LLC v. Apotex Corp., 15-0287 (D.N.J.) Jan. 14, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection)
5,847,170
7,241,907
Sanofi-Aventis U.S. LLC v. Breckenridge Pharm., Inc., 15-0289 (D.N.J.) Jan. 14, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection)
5,847,170
7,241,907
Sanofi-Aventis U.S. LLC v. Onco Therapies Ltd., 15-0290 (D.N.J.) Jan. 14, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection)
5,847,170
7,241,907
Sanofi-Aventis U.S. LLC v. Apotex Corp., 15-0044 (D. Del.) Jan. 15, 2015 Hon. Leonard P. Stark Jevtana® Kit (cabazitaxel injection)
5,847,170
7,241,907
Sanofi-Aventis U.S. LLC v. Breckenridge Pharm., Inc., 15-80056 (S.D. Fla.) Jan. 15, 2015 Hon. Donald M. Middlebrooks Jevtana® Kit (cabazitaxel injection)
5,847,170
7,241,907
Laboratoire HRA Pharma v. Teva Pharms. USA, Inc., 15-0045 (D. Del.) Jan. 16, 2015 Hon. Richard G. Andrews Ella® (ulipristal acetate oral tablets)
8,426,392
8,512,745
8,735,380
Boehringer Ingelheim GmbH & Co. KG v. Teva Pharms. USA, Inc., 15-0048 (D. Del.) Jan. 16, 2015 Hon. Sue L. Robinson Pradaxa® (dabigatran etexilate mesylate capsules) 6,087,380
Shionogi & Co., Ltd. v. Aurobindo Pharma Ltd., 15-0319 (D.N.J.) Jan. 16, 2015 Hon. Michael A. Shipp Doribax® (doripenem for injection) 8,247,402
Supernus Pharms., Inc. v. Par Pharm. Cos., Inc., 15-0326 (D.N.J.) Jan. 16, 2015 Hon. Susan D. Wigenton Trokendi XR® (topiramate extended-release capsules)
8,298,576
8,298,580
8,663,683
8,877,248
Senju Pharm. Co., Ltd. v. Lupin, Ltd., 15-0335 (D.N.J.) Jan. 16, 2015 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution)
8,871,813
8,927,606
Senju Pharm. Co., Ltd. v. Apotex Inc., 15-0336 (D.N.J.) Jan. 16, 2015 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution)
8,129,431
8,669,290
8,754,131
8,871,813
8,927,606
Senju Pharm. Co., Ltd. v. Paddock Labs., LLC, 15-0337 (D.N.J.) Jan. 16, 2015 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution)
8,129,431
8,669,290
8,754,131
8,871,813
8,927,606
Supernus Pharms., Inc. v. TWi Pharms., Inc., 15-0369 (D.N.J.) Jan. 16, 2015 Hon. Renee Marie Bumb Oxtellar XR® (oxcarbazepine extended-release tablets)
7,722,898
7,910,131
8,617,600
8,821,930
Shionogi & Co., Ltd. v. Aurobindo Pharma Ltd., 15-0478 (N.D. Ill.) Jan. 16, 2015 Hon. Robert W. Gettleman Doribax® (doripenem for injection) 8,247,402
Teva Pharms. USA, Inc. v. AstraZeneca Pharms. LP, 15-0050 (D. Del.) Jan. 19, 2015 Hon. Gregory M. Sleet Byetta® (exenatide injection)
7,297,761
7,741,269
Tris Pharma Inc. v. Par Pharm., Inc., 15-0068 (D. Del.) Jan. 21, 2015 Hon. Gregory M. Sleet
Quillivant XR® (methylphenidate hydrochloride
extended-release oral suspension)
8,062,667
8,287,903
8,465,765
8,563,033
8,778,390
Boehringer Ingelheim GmbH & Co. KG v. Mylan Pharms. Inc., 15-0010 (N.D.W.V.) Jan. 21, 2015 Hon. Irene M. Keeley Pradaxa® (dabigatran etexilate mesylate capsules) 6,087,380
Teva Pharms. USA, Inc. v. Dr. Reddy’s Labs., Ltd., 15-0471 (D.N.J.) Jan. 22, 2015 Hon. Claire C. Cecchi Copaxone® (glatiramer acetate for injection) 5,800,808
Teva Pharms. USA, Inc. v. Synthon Pharms., Inc., 15-0472 (D.N.J.) Jan. 22, 2015 Hon. Claire C. Cecchi Copaxone® (glatiramer acetate for injection) 5,800,808
Acorda Therapeutics, Inc. v. Actavis Labs. FL, Inc., 15-0077 (D. Del.) Jan. 23, 2015 Hon. Leonard P. Stark Ampyra® (dalfampridine extended-release tablets) 5,540,938
Novartis Pharms. Corp. v. Par Pharm., Inc., 15-0078 (D. Del.) Jan. 23, 2015 Hon. Richard G. Andrews Afinitor® (everolimus tablets)
5,665,772
7,297,703
7,741,338
Pfizer Inc. v. Mylan Pharms. Inc., 15-0079 (D. Del.) Jan. 23, 2015 Hon. Gregory M. Sleet Toviaz® (fesoterodine fumarate extended-release tablets)
6,858,650
7,384,980
7,855,230
7,985,772
8,338,478
Astellas Pharma Inc. v. Fresenius Kabi USA, LLC, 15-0080 (D. Del.) Jan. 23, 2015 Hon. Leonard P. Stark Mycamine® (micafungin sodium for injection)
6,107,458
6,774,104
Eli Lilly and Co. v. Fresenius Kabi USA, LLC, 15-0096 (S.D. Ind.) Jan. 23, 2015 Hon. Tanya Walton Pratt Alimta® (pemetrexed disodium for intravenous infusion) 7,772,209
Spectrum Pharms., Inc. v. Amneal Pharms. LLC, 15-0139 (D. Nev.) Jan. 23, 2015 Hon. James C. Mahan Fusilev® (levoleucovorin calcium for injection) 6,500,829
Senju Pharm. Co., Ltd. v. Paddock Labs., LLC, 15-0087 (D. Del.) Jan. 26, 2015 Hon. Sue L. Robinson Prolensa® (bromfenac ophthalmic solution)
8,129,431
8,669,290
8,754,131
8,871,813
8,927,606
AstraZeneca Pharms. LP v. Glenmark Pharms. Ltd., 15-0615 (D.N.J.) Jan. 26, 2015 Hon. Renee Marie Bumb Faslodex® (fulvestrant injection)
6,774,122
7,456,160
8,329,680
8,466,139
Pfizer Inc. v. Mylan Pharms. Inc., 15-0013 (N.D.W.V.) Jan. 27, 2015 Hon. Irene M. Keeley Toviaz® (fesoterodine fumarate extended-release tablets)
6,858,650
7,384,980
7,855,230
7,985,772
8,338,478
Otsuka Pharm. Co., Ltd. v. Apotex Inc., 15-0109 (D. Del.) Jan. 29, 2015 Hon. Richard G. Andrews Samsca® (tolvaptan tablets)
5,753,677
8,501,730
Bayer Healthcare LLC v. Mylan Pharms. Inc., 15-0114 (D. Del.) Jan. 30, 2015 Hon. Leonard P. Stark Nexavar® (sorafenib tosylate tablets)
8,618,141
8,877,933
Shionogi & Co., Ltd. v. Apotex Corp., 15-0668 (D.N.J.) Jan. 30, 2015 Hon. Peter G. Sheridan Doribax® (doripenem for injection) 8,247,402
Celgene Corp. v. Lannett Holdings, Inc., 15-0697 (D.N.J.) Jan. 30, 2015 Hon. Susan D. Wigenton Thalomid® (thalidomide capsules)
6,045,501
6,315,720
6,561,976
6,561,977
6,755,784
6,869,399
7,141,018
7,230,012
7,435,745
7,874,984
7,959,566
8,204,763
8,315,886
8,589,188
8,626,531
Cosmo Technologies Ltd. v. Par Pharm., Inc., 15-0116 (D. Del.) Feb. 2, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets)
7,410,651
7,431,943
8,293,273
8,784,888
8,895,064
RE43,799
Cephalon, Inc. v. Unimark Remedies Ltd., 15-0117 (D. Del.) Feb. 2, 2015 Hon. Gregory M. Sleet Nuvigil® (armodafinil tablets) 7,132,570
Sanofi-Aventis U.S. LLC v. Actavis LLC, 15-0776 (D.N.J.) Feb. 2, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection)
5,847,170
7,241,907
Teva Pharms. USA, Inc. v. Amneal Pharms. LLC, 15-0124 (D. Del.) Feb. 3, 2015 Hon. Gregory M. Sleet Copaxone® (glatiramer acetate for injection)
8,232,250
8,399,413
Mylan Pharms. Inc. v. Warner-Chilcott Co. LLC, IPR2015-00682 (PTAB) Feb. 3, 2015 N/A
Lo Loestrin® Fe
(ethinyl estradiol / norethindrone acetate tablets)
7,704,984
Orexo AB v. Actavis Labs. FL, Inc., 15-0826 (D.N.J.) Feb. 4, 2015 Hon. Peter G. Sheridan Abstral® (fentanyl sublingual tablets)
6,759,059
6,761,910
7,910,132
AstraZeneca AB v. Perrigo Co. PLC, 15-1057 (D.N.J.) Feb. 4, 2015 Hon. Mary L. Cooper
Nexium 24HR®
(esomeprazole magnesium delayed-release capsules)
6,369,085
7,411,070
Novartis Pharms. Corp. v. Roxane Labs., Inc., 15-0128 (D. Del.) Feb. 5, 2015 Hon. Richard G. Andrews Afinitor® (everolimus tablets)
5,665,772
7,297,703
7,741,338
Novartis Pharms. Corp. v. BPI Labs LLC, 15-0950 (D.N.J.) Feb. 5, 2015 Hon. Susan D. Wigenton Zometa® (zoledronic acid for injection) 8,324,189
Jazz Pharms., Inc. v. Amneal Pharms., LLC, 15-1043 (D.N.J.) Feb. 6, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution)
8,731,963
8,772,306
8,859,619
Dr. Reddy’s Labs., Inc. v. Fresenius Kabi USA, LLC, IPR2015-00715 (PTAB) Feb. 6, 2015 N/A Diprivan® (propofol injectable) 8,476,010
Mylan Pharms. Inc. v. Yeda Research & Development Co. Ltd., IPR2015-00644 (PTAB) Feb. 7, 2015 N/A Copaxone® (glatiramer acetate for injection) 8,399,413
Novartis Pharms. Corp. v. BPI Labs, LLC, 15-0272 (M.D. Fla.) Feb. 9, 2015 Hon. Susan C Bucklew Zometa® (zoledronic acid for injection) 8,324,189
Roxane Labs., Inc. v. Lupin Ltd., 15-1095 (D.N.J.) Feb. 10, 2015 Hon. Stanley R. Chesler PhosLo® GelCaps (calcium acetate capsules) 8,563,032
Novartis AG v. Ezra Ventures, LLC, 15-0150 (D. Del.) Feb. 11, 2015 Hon. Leonard P. Stark Gilenya® (fingolimod hydrochloride capsules) 5,604,229
Novartis AG v. HEC Pharm Co., Ltd., 15-0151 (D. Del.) Feb. 11, 2015 Hon. Leonard P. Stark Gilenya® (fingolimod hydrochloride capsules) 5,604,229
Novo Nordisk Inc. v. Sun Pharm. Indus. Ltd., 15-1287 (D.N.J.) Feb. 12, 2015 Hon. Michael A. Shipp Vagifem® (estradiol tablets) 7,018,992
Forest Labs., LLC v. Alembic Pharms. Ltd., 15-0158 (D. Del.) Feb. 13, 2015 Hon. Sue L. Robinson Saphris® (asenapine maleate tablets) 5,763,476
AbbVie, Inc. v. Mylan Pharms. Inc., 15-1402 (N.D. Ill.) Feb. 13, 2015 Hon. Robert W. Gettleman Kaletra® (lopinavir / ritonavir tablets)
8,025,899
8,268,349
8,309,613
8,377,952
8,399,015
8,470,347
8,691,878
Helsinn Healthcare S.A. v. Gavis Pharma LLC, 15-1228 (D.N.J.) Feb. 13, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride IV solution)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Novartis AG v. Ezra Ventures, LLC, 15-0095 (E.D. Ark.) Feb. 13, 2015 Hon. Kristine G. Baker Gilenya® (fingolimod hydrochloride capsules) 5,604,229
Cosmo Technologies Ltd. v. Actavis Labs. FL, Inc., 15-0164 (D. Del.) Feb. 17, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets)
7,410,651
7,431,943
8,293,273
8,784,888
8,895,064
RE43,799
INO Therapeutics LLC v. Praxair Distribution, Inc., 15-170 (D. Del.) Feb. 19, 2015 Hon. Gregory M. Sleet INOmax® (nitric oxide for inhalation)
8,282,966
8,293,284
8,431,163
8,795,741
8,846,112
8,291,904
8,573,210
8,573,209
8,776,794
8,776,795
Cosmo Technologies Ltd. v. Actavis Labs. FL, Inc., 15-1312 (D.N.J.) Feb. 19, 2015 Hon. Madeline C. Arleo Uceris® (budesonide tablets)
7,410,651
7,431,943
8,293,273
8,784,888
8,895,064
RE43,799
Ferring Pharms. Inc. v. Par Pharm., Inc., 15-0173 (D. Del.) Feb. 20, 2015 Hon. Richard G. Andrews
Prepopik®
(sodium picosulfate / magnesium oxide / citric acid solution)
8,450,338
8,481,083
Fresenius Medical Care Holdings, Inc. v. Novel Labs., Inc., 15-10472 (D. Mass.) Feb. 20, 2015 Hon. Richard G. Stearns PhosLo® GelCaps (calcium acetate)
6,576,665
6,875,445
Jazz Pharms., Inc. v. Roxane Labs., Inc., 15-1360 (D.N.J.) Feb. 20, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution)
8,461,203
8,772,306
8,859,619
Fresenius Medical Care Holdings, Inc. v. Novel Labs., Inc., 15-1361 (D.N.J.) Feb. 20, 2015 Hon. Peter G. Sheridan PhosLo® GelCaps (calcium acetate)
6,576,665
6,875,445
Cephalon, Inc. v. Sandoz Inc., 15-0178 (D. Del.) Feb. 23, 2015 Hon. Gregory M. Sleet Treanda® (bendamustine hydrochloride for infusion)
8,669,279
8,883,836
8,895,756
Cephalon, Inc. v. Dr. Reddy’s Labs., Ltd., 15-0179 (D. Del.) Feb. 23, 2015 Hon. Gregory M. Sleet Treanda® (bendamustine hydrochloride for infusion)
8,669,279
8,883,836
8,895,756
Shire LLC v. Par Pharm., Inc., 15-1454 (D.N.J.) Feb. 26, 2015 Hon. Renee Marie Bumb

 

 

Adderall XR® (dextroamphetamine sulfate /
dextroamphetamine saccharate /
amphetamine aspartate monohydrate /
amphetamine sulfate tablets)
RE42,096
RE41,148
Purdue Pharma L.P. v. Actavis Labs. UT, Inc., 15-0192 (D. Del.) Feb. 27, 2015 Hon. Sue L. Robinson Butrans® (buprenorphine transdermal system)
RE41,408
RE41,489
RE41,571
Cosmo Technologies Ltd. v. Alvogen Pine Brook, Inc., 15-0193 (D. Del.) Feb. 27, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets)
7,410,651
8,784,888
RE43,799
AstraZeneca Pharms. LP v. Macleods Pharms., Ltd., 15-1513 (D.N.J.) Feb. 27, 2015 Hon. Claire C. Cecchi
Seroquel XR®
(quetiapine fumarate extended-release tablets)
5,948,437
Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc., IPR2015-00817 (PTAB) Feb. 27, 2015 N/A Ampyra® (dalfampridine extended-release tablets) 8,007,826
Otsuka Pharm. Co., Ltd. v. Amneal Pharms. LLC, 15-1585 (D.N.J.) Mar. 2, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,017,615
8,580,796
8,642,760
8,759,350
Mylan Pharms. Inc. v. Yeda Research & Development Co. Ltd., IPR2015-00830 (PTAB) Mar. 3, 2015 N/A
Copaxone®
(glatiramer acetate for injection)
8,969,302
Vivus, Inc. v. Actavis Labs. FL, Inc., 15-1636 (D.N.J.) Mar. 4, 2015 Hon. Stanley R. Chesler
Qsymia® (phentermine /
topiramate extended-release capsules)
8,895,057
8,895,058
Novartis AG v. HEC Pharm Co., Ltd., 15-1647 (D.N.J.) Mar. 5, 2015 Hon. Claire C. Cecchi Gilenya® (fingolimod hydrochloride capsules) 5,604,229
Boehringer Ingelheim Pharma GMBH & Co. KG v. Breckenridge Pharm., Inc., 15-1662 (D.N.J.) Mar. 5, 2015 Hon. Mary L. Cooper Pradaxa® (dabigatran etexilate mesylate capsules) 6,087,380
Baxter Healthcare Corp. v. Sagent Pharms. Inc., 15-1684 (D.N.J.) Mar. 6, 2015 Hon. Jerome B. Simandle
Brevibloc®
(esmolol hydrochloride in sodium chloride solution)
6,310,094
6,528,540
Otsuka Pharm. Co., Ltd. v. Wockhardt Bio AG, 15-1690 (D.N.J.) Mar. 6, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,759,350
7,053,092
Biomarin Pharm. Inc. v. Par Pharm., Inc., 15-1706 (D.N.J.) Mar. 6, 2015 Hon. Michael A. Shipp Kuvan® (sapropterin dihydrochloride tablets)
7,566,462
7,566,714
7,612,073
7,727,987
8,003,126
8,067,416
RE43,797
8,318,745
Baxter Healthcare Corp. v. Sagent Pharms. Inc., 15-2076 (N.D. Ill.) Mar. 9, 2015 Hon. Richard A. Posner
Brevibloc®
(esmolol hydrochloride in sodium chloride solution)
6,310,094
6,528,540
Otsuka Pharm. Co., Ltd. v. Sandoz Inc., 15-1716 (D.N.J.) Mar. 9, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,017,615
8,580,796
8,642,760
8,759,350
Allergan Sales, LLC v. Sandoz, Inc., 15-0347 (E.D. Tex.) Mar. 9, 2015 Hon. Rodney Gilstrap
Combigan® (brimonidine tartrate /
timolol maleate ophthalmic solution)
7,030,149
7,320,976
7,642,258
8,748,425
Ferrum Ferro Capital, LLC v. Allergan Sales, LLC, IPR2015-00858 (PTAB) Mar. 9, 2015 N/A
Combigan®
(brimonidine tartrate /
timolol maleate ophthalmic solution)
7,030,149
Sanofi-Aventis U.S. LLC v. Apotex Corp., 15-1835 (D.N.J.) Mar. 11, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection) 8,927,592
Sanofi-Aventis U.S. LLC v. Breckenridge Pharm., Inc., 15-1836 (D.N.J.) Mar. 11, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection) 8,927,592
Galderma Labs., L.P. v. Actavis Labs. UT, Inc., 15-0232 (D. Del.) Mar. 12, 2015 Hon. Leonard P. Stark Mirvaso® (brimonidine topical gel)
7,439,241
8,410,102
8,426,410
8,859,551
8,513,247
8,513,249
Accord Healthcare Inc. v. Daiichi Sankyo Co., Ltd., IPR2015-00864 (PTAB) Mar. 12, 2015 N/A Effient® (prasugrel hydrochloride tablets) 8,404,703
Accord Healthcare Inc. v. Daiichi Sankyo Co., Ltd., IPR2015-00865 (PTAB) Mar. 13, 2015 N/A Effient® (prasugrel hydrochloride tablets) 8,569,325
Apotex Inc. v. Wyeth LLC, IPR2015-00873 (PTAB) Mar. 12, 2015 N/A Tygacil® (tigecycline injectable IV infusion) 7,879,828
Horizon Pharma Ireland Ltd. v. Taro Pharms. USA, Inc., 15-2046 (D.N.J.) Mar. 13, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
8,217,078
8,252,838
8,546,450
8,563,613
8,618,164
8,871,809
Praxair Distribution, Inc. v. iNO Therapeutics, LLC, IPR2015-00884 (PTAB) Mar. 16, 2015 N/A INOmax® (nitric oxide) 8,291,904
Praxair Distribution, Inc. v. iNO Therapeutics, LLC, IPR2015-00888 (PTAB) Mar. 16, 2015 N/A INOmax® (nitric oxide) 8,776,794
Praxair Distribution, Inc. v. iNO Therapeutics, LLC, IPR2015-00889 (PTAB) Mar. 16, 2015 N/A INOmax® (nitric oxide) 8,573,209
Praxair Distribution, Inc. v. iNO Therapeutics, LLC, IPR2015-00891 (PTAB) Mar. 16, 2015 N/A INOmax® (nitric oxide) 8,573,210
Praxair Distribution, Inc. v. iNO Therapeutics, LLC, IPR2015-00893 (PTAB) Mar. 16, 2015 N/A INOmax® (nitric oxide) 8,776,795
Bristol-Myers Squibb Co. v. Mylan Pharms., Inc., 15-1949 (D.N.J.) Mar. 17, 2015 Hon. Freda L. Wolfson Reyataz® (atazanavir sulfate capsules) 6,087,383
Otsuka Pharm. Co., Ltd. v. Indoco Remedies Ltd., 15-1967 (D.N.J.) Mar. 17, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,017,615
8,580,796
8,642,760
8,759,350
Bristol-Myers Squibb Co. v. Mylan Pharms., Inc., 15-0049 (N.D.W.V.) Mar. 19, 2015 Hon. Irene M. Keeley Reyataz® (atazanavir sulfate capsules) 6,087,383
Innopharma Licensing, Inc. v. Senju Pharm. Co., Ltd., IPR2015-00902 (PTAB) Mar. 19, 2015 N/A Prolensa® (bromfenac ophthalmic solution) 8,669,290
Innopharma Licensing, Inc. v. Senju Pharm. Co., Ltd., IPR2015-00903 (PTAB) Mar. 19, 2015 N/A Prolensa® (bromfenac ophthalmic solution) 8,129,431
Noven Pharms., Inc. v. Actavis Labs. UT, Inc., 15-0249 (D. Del.) Mar. 20, 2015 Hon. Leonard P. Stark Minivelle® (estradiol transdermal system) 8,231,906
Merck Sharp & Dohme Corp. v. Amneal Pharms. LLC, 15-0250 (D. Del.) Mar. 20, 2015 Hon. Sue L. Robinson Nasonex® (mometasone furoate monohydrate metered nasal spray) 6,127,353
Boehringer Ingelheim Pharma GmbH & Co. KG v.
Breckenridge Pharm., Inc., 15-80377 (S.D. Fla.)
Mar. 20, 2015 Hon. Kenneth A. Marra Pradaxa® (dabigatran etexilate mesylate capsules)) 6,087,380
Helsinn Healthcare S.A. v. Hospira, Inc., 15-2077 (D.N.J.) Mar. 23, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride IV solution)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Helsinn Healthcare S.A. v. Par Pharm. Cos., Inc., 15-2078 (D.N.J.) Mar. 23, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride IV solution)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Purdue Pharma L.P. v. Collegium Pharm., Inc., 15-0260 (D. Del.) Mar. 24, 2015 Hon. Sue L. Robinson OxyContin® (oxycodone hydrochloride extended-release tablets)
7,674,799
7,674,800
7,683,072
8,652,497
Helsinn Healthcare S.A. v. Hospira, Inc., 15-0264 (D. Del.) Mar. 25, 2015 Hon. Gregory M. Sleet Aloxi® (palonosetron hydrochloride IV solution)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Helsinn Healthcare S.A. v. Par Pharm. Cos., Inc., 15-0265 (D. Del.) Mar. 25, 2015 Hon. Gregory M. Sleet Aloxi® (palonosetron hydrochloride IV solution)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Purdue Pharma L.P. v. Collegium Pharm., Inc., 15-11294 (D. Mass.) Mar. 26, 2015 Hon. F. Dennis Saylor, IV OxyContin® (oxycodone hydrochloride extended-release tablets)
7,674,799
7,674,800
7,683,072
8,652,497
Reckitt Benckiser LLC v. Amneal Pharms LLC, 15-2155 (D.N.J.) Mar. 26, 2015 Hon. Claire C. Cecchi Mucinex® (guaifenesin extended-release tablets)
6,372,252
6,955,821
7,838,032
Reckitt Benckiser LLC v. Perrigo Co., 15-2156 (D.N.J.) Mar. 26, 2015 Hon. Claire C. Cecchi Mucinex® (guaifenesin extended-release tablets)
6,372,252
6,955,821
7,838,032
Novo Nordisk Inc. v. Baxter Healthcare Corp., 15-2157 (D.N.J.) Mar. 26, 2015 Hon. Peter G. Sheridan Novoeight® (turoctocog alfa)
6,100,061
6,475,725
6,936,441
7,094,574
8,080,414
8,084,251
8,084,252
8,329,465
Forest Labs., LLC v. Accord Healthcare Inc., 15-0272 (D. Del.) Mar. 27, 2015 Hon. Gregory M. Sleet Viibryd® (vilazodone tabletsa)
7,834,020
8,193,195
8,236,804
8,673,921
Forest Labs., LLC v. Alembic Pharms. Ltd., 15-0273 (D. Del.) Mar. 27, 2015 Hon. Gregory M. Sleet Viibryd® (vilazodone tabletsa)
7,834,020
8,193,195
8,236,804
8,673,921
Forest Labs., LLC v. Apotex Inc., 15-0274 (D. Del.) Mar. 27, 2015 Hon. Gregory M. Sleet Viibryd® (vilazodone tabletsa)
7,834,020
8,193,195
8,236,804
8,673,921
Forest Labs., LLC v. Teva Pharms. USA, Inc., 15-0275 (D. Del.) Mar. 27, 2015 Hon. Gregory M. Sleet Viibryd® (vilazodone tabletsa)
7,834,020
8,193,195
8,236,804
8,673,921
McNeil-PPC, Inc. v. Watson Labs., Inc., 15-2197 (D.N.J.) Mar. 27, 2015 Hon. Madeline C. Arleo Rogaine® (5% minoxidil topical aerosol foam) 6,946,120
Forest Labs., LLC v. Invagen Pharms. Inc., 15-0277 (D. Del.) Mar. 30, 2015 Hon. Gregory M. Sleet Viibryd® (vilazodone tabletsa)
7,834,020
8,193,195
8,236,804
8,673,921

Back to Top